Filing Details
- Accession Number:
- 0001209191-19-015629
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 16:26:59
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 16:26:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1310803 | N Badri Dasu | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Engineering Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-28 | 9,206 | $2.81 | 113,267 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Balance includes non-reportable acquisition of 9,206 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
